Drug pricing experts skeptical that Florida’s drug import plan will worknews2024-01-05T21:09:44+00:00January 5th, 2024|Endpoints News|
Califf and Marks call for clinicians to help address ‘large volume’ of vaccine misinformationnews2024-01-05T20:49:57+00:00January 5th, 2024|Endpoints News|
Illumina board members allege activist director gave confidential information to Icahn for use in lawsuitnews2024-01-05T19:34:04+00:00January 5th, 2024|Endpoints News|
GSK’s ViiV sponsors new season of RuPaul TV show to spark HIV prevention conversationsnews2024-01-05T19:33:42+00:00January 5th, 2024|Endpoints News|
Semaglutide associated with lower risk of suicidal ideations compared to non-GLP-1 drugs: NIH-funded studynews2024-01-05T19:03:11+00:00January 5th, 2024|Endpoints News|
Fusion Pharma marks in-house radiopharma manufacturing success, details PhII/III trial studynews2024-01-05T16:28:20+00:00January 5th, 2024|Endpoints News|
Sage Therapeutics’ triumph in postpartum depression, and the failure that followednews2024-01-05T16:24:03+00:00January 5th, 2024|Endpoints News|
Novartis adds Indianapolis site to its manufacturing capacity for radioligand drug Pluvictonews2024-01-05T16:06:23+00:00January 5th, 2024|Endpoints News|
Merck CEO indicates interest in GLP-1 combination therapies, may pursue dealsnews2024-01-05T16:06:17+00:00January 5th, 2024|Endpoints News|
IQVIA and Propel abandon merger after FTC probe and injunctionnews2024-01-05T15:32:46+00:00January 5th, 2024|Endpoints News|
